53.03

0.42% 0.22

Procept Biorobotics Corp (PRCT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$52.81

Aprire:

$52.66

Volume 24 ore:

868.29K

Relative Volume:

0.90

Capitalizzazione di mercato:

$2.95B

Reddito:

$199.84M

Utile/perdita netta:

$-100.06M

Rapporto P/E:

-27.19

EPS:

-1.95

Flusso di cassa netto:

$-103.57M

1 W Prestazione:

+4.53%

1M Prestazione:

-10.16%

6M Prestazione:

-23.23%

1 anno Prestazione:

+2.39%

Intervallo 1D:

$52.13

$53.19

Intervallo di 1 settimana:

$49.03

$54.74

Portata 52W:

$47.04

$103.81

Procept Biorobotics Corp Stock (PRCT) Company Profile

Nome

Procept Biorobotics Corp

Settore

Healthcare (1151)

Industria

Medical Devices (153)

Telefono

(650) 232-9832

Indirizzo

150 BAYTECH DRIVE, SAN JOSE

Dipendente

756

Cinguettio

Prossima data di guadagno

2024-10-28

Ultimi documenti SEC

PRCT's Discussions on Twitter

Confronta PRCT con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
PRCT Procept Biorobotics Corp	53.03	2.95B	199.84M	-100.06M	-103.57M	-1.95
ABT Abbott Laboratories	130.98	221.92B	41.95B	13.40B	6.35B	7.65
BSX Boston Scientific Corp	95.12	139.43B	16.75B	1.85B	2.37B	1.25
SYK Stryker Corp	346.50	134.90B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	82.60	108.02B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	71.53	40.93B	5.72B	4.17B	259.90M	6.97

Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-12-02	Iniziato	Morgan Stanley	Overweight
2024-11-14	Iniziato	Jefferies	Hold
2023-08-11	Iniziato	Piper Sandler	Overweight
2023-05-31	Iniziato	William Blair	Outperform
2022-10-31	Iniziato	BTIG Research	Neutral
2022-10-25	Iniziato	Truist	Buy
2022-09-02	Iniziato	Wells Fargo	Overweight
2022-07-15	Iniziato	KeyBanc Capital Markets	Overweight
2022-06-23	Iniziato	B. Riley Securities	Buy
2021-10-11	Iniziato	BofA Securities	Buy
2021-10-11	Iniziato	Cowen	Outperform
2021-10-11	Iniziato	Goldman	Neutral
2021-10-11	Iniziato	Guggenheim	Buy
2021-10-11	Iniziato	SVB Leerink	Outperform

Mostra tutto

Procept Biorobotics Corp Borsa (PRCT) Ultime notizie

Apr 18, 2025

Piper Sandler maintains $100 target on Procept BioRobotics stock By Investing.com - Investing.com Canada

Apr 18, 2025

Apr 17, 2025

Piper Sandler maintains $100 target on Procept BioRobotics stock - Investing.com Australia

Apr 17, 2025

Apr 16, 2025

Analysts Set PROCEPT BioRobotics Co. (NASDAQ:PRCT) PT at $91.43 - Defense World

Apr 16, 2025

Apr 14, 2025

Truist Financial Cuts PROCEPT BioRobotics (NASDAQ:PRCT) Price Target to $70.00 - Defense World

Apr 14, 2025

Apr 10, 2025

Leading Urologists Join PROCEPT BioRobotics Leadership for Exclusive Investor Insights - Stock Titan

Apr 10, 2025

Commonwealth Equity Services LLC Buys New Holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World

Apr 10, 2025

Apr 06, 2025

JPMorgan Chase & Co. Lowers Stock Holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World

Apr 06, 2025

Apr 03, 2025

Vanguard Group Inc. Purchases 297,075 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World

Apr 03, 2025

Corebridge Financial Inc. Sells 496 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World

Apr 03, 2025

Apr 02, 2025

Raymond James Financial Inc. Purchases Shares of 20,453 PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World

Apr 02, 2025

Apr 01, 2025

HighTower Advisors LLC Buys 1,026 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World

Apr 01, 2025

Mar 31, 2025

Sei Investments Co. Grows Stake in PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World

Mar 31, 2025

Teacher Retirement System of Texas Takes Position in PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World

Mar 31, 2025

Mar 29, 2025

PROCEPT BioRobotics (PRCT): One of the Best Robotics Stocks to Buy According to Billionaires - Insider Monkey

Mar 29, 2025

Mar 28, 2025

10 Best Robotics Stocks to Buy According to Billionaires - Insider Monkey

Mar 28, 2025

Mar 24, 2025

Aquablation therapy shows promise in prostate treatment By Investing.com - Investing.com Australia

Mar 24, 2025

Aquablation therapy shows promise in prostate treatment - Investing.com India

Mar 24, 2025

PROCEPT BioRobotics Announces Positive Results for Aquablation Therapy in WATER III Trial Presented at EAU 2025 Annual Congress - Nasdaq

Mar 24, 2025

New Clinical Data: Aquablation Reduces Sexual Side Effects by 80% vs Traditional Prostate Treatment - Stock Titan

Mar 24, 2025

PNC Financial Services Group Inc. Sells 1,582 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World

Mar 24, 2025

Mar 23, 2025

Swiss National Bank Has $7.82 Million Stock Holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World

Mar 23, 2025

Mar 22, 2025

PROCEPT BioRobotics Co. (NASDAQ:PRCT) Receives $94.29 Consensus Target Price from Analysts - Defense World

Mar 22, 2025

Mar 20, 2025